NCT07198347View on ClinicalTrials.gov

Efficacy and Safety of AG2001 in Patients With Acute Bronchitis

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

October 31, 2026

Conditions
Acute Bronchitis
Interventions
DRUG

AG2001

Oral administration, three times daily for 7 days.

DRUG

AG20011

Oral administration, three times daily for 7 days.

DRUG

AG20012

Oral administration, three times daily for 7 days.

Sponsors
All Listed Sponsors
lead

Ahn-Gook Pharmaceuticals Co.,Ltd

INDUSTRY

NCT07198347 - Efficacy and Safety of AG2001 in Patients With Acute Bronchitis | Biotech Hunter | Biotech Hunter